248 related articles for article (PubMed ID: 16896290)
1. Advances in the treatment of juvenile dermatomyositis.
Stringer E; Feldman BM
Curr Opin Rheumatol; 2006 Sep; 18(5):503-6. PubMed ID: 16896290
[TBL] [Abstract][Full Text] [Related]
2. [Juvenile dermatomyositis in the Nice area: a retrospective study 1991-2001].
Jäger C; Sirvent N; Rabasse N; Soler C; Sebag F; Boutte P; Lacour JP
Ann Dermatol Venereol; 2002 Oct; 129(10 Pt 1):1120-4. PubMed ID: 12442123
[TBL] [Abstract][Full Text] [Related]
3. [Juvenile dermatomyositis: diagnosis and treatment].
Gissinger-Prévot S; Figarella-Branger D; Mancini J; Chabrol B
Arch Pediatr; 2008 Jan; 15(1):50-3. PubMed ID: 18164188
[TBL] [Abstract][Full Text] [Related]
4. Rituximab for the treatment of juvenile dermatomyositis: a report of four pediatric patients.
Cooper MA; Willingham DL; Brown DE; French AR; Shih FF; White AJ
Arthritis Rheum; 2007 Sep; 56(9):3107-11. PubMed ID: 17763414
[TBL] [Abstract][Full Text] [Related]
5. Ten-year experience of juvenile dermatomyositis: a retrospective study.
Chiu SK; Yang YH; Wang LC; Chiang BL
J Microbiol Immunol Infect; 2007 Feb; 40(1):68-73. PubMed ID: 17332910
[TBL] [Abstract][Full Text] [Related]
6. Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety.
Riley P; Maillard SM; Wedderburn LR; Woo P; Murray KJ; Pilkington CA
Rheumatology (Oxford); 2004 Apr; 43(4):491-6. PubMed ID: 14722349
[TBL] [Abstract][Full Text] [Related]
7. National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary--clinical characteristics and disease course of 44 patients with juvenile dermatomyositis.
Constantin T; Ponyi A; Orbán I; Molnár K; Dérfalvi B; Dicso F; Kálovics T; Müller J; Garami M; Sallai A; Balogh Z; Szalai Z; Fekete G; Dankó K
Autoimmunity; 2006 May; 39(3):223-32. PubMed ID: 16769656
[TBL] [Abstract][Full Text] [Related]
8. Juvenile dermatomyositis: extramuscular manifestations and their management.
Lowry CA; Pilkington CA
Curr Opin Rheumatol; 2009 Nov; 21(6):575-80. PubMed ID: 19730375
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety.
Al-Mayouf SM; Laxer RM; Schneider R; Silverman ED; Feldman BM
J Rheumatol; 2000 Oct; 27(10):2498-503. PubMed ID: 11036850
[TBL] [Abstract][Full Text] [Related]
10. [Two children with skin rash and muscle weakness: juvenile dermatomyositis].
Boogaard R; Drexhage VR; van Suijlekom-Smit LW
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):146-50. PubMed ID: 15693592
[TBL] [Abstract][Full Text] [Related]
11. [Intravenously-administered immunoglobulins as first-choice agent in juvenile dermatomyositis].
Breems DA; de Haas PW; Visscher F; Sabbe LJ; Busch HF; van Doorn PA
Ned Tijdschr Geneeskd; 1993 Sep; 137(39):1979-82. PubMed ID: 8413708
[TBL] [Abstract][Full Text] [Related]
12. Rituximab for the treatment of the skin manifestations of dermatomyositis: a report of 3 cases.
Dinh HV; McCormack C; Hall S; Prince HM
J Am Acad Dermatol; 2007 Jan; 56(1):148-53. PubMed ID: 17097377
[TBL] [Abstract][Full Text] [Related]
13. Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features.
Stringer E; Singh-Grewal D; Feldman BM
Arthritis Rheum; 2008 Nov; 58(11):3585-92. PubMed ID: 18975314
[TBL] [Abstract][Full Text] [Related]
14. [Dermatomyositis in children: clinical course of 9 cases].
García Consuegra J; Antelo MC; Torreblanca J
An Esp Pediatr; 1987 Nov; 27(5):362-6. PubMed ID: 3439658
[TBL] [Abstract][Full Text] [Related]
15. Predictability of the clinical course of juvenile dermatomyositis based on initial muscle biopsy: a retrospective study of 72 patients.
Miles L; Bove KE; Lovell D; Wargula JC; Bukulmez H; Shao M; Salisbury S; Bean JA
Arthritis Rheum; 2007 Oct; 57(7):1183-91. PubMed ID: 17907236
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis.
Riley P; McCann LJ; Maillard SM; Woo P; Murray KJ; Pilkington CA
Rheumatology (Oxford); 2008 Jun; 47(6):877-80. PubMed ID: 18403404
[TBL] [Abstract][Full Text] [Related]
17. Clinical assessment in juvenile dermatomyositis.
Ravelli A; Ruperto N; Trail L; Felici E; Sala E; Martini A
Autoimmunity; 2006 May; 39(3):197-203. PubMed ID: 16769653
[TBL] [Abstract][Full Text] [Related]
18. Clinical case of the month. 3-year-old boy presenting with a hand rash. Juvenile dermatomyositis.
Kendrick CG; Poole JC; Nicotri T; Gedalia A; Lopez FA
J La State Med Soc; 2004; 156(5):235-9; quiz 240. PubMed ID: 15554092
[TBL] [Abstract][Full Text] [Related]
19. Safety of intravenous immunoglobulin in the treatment of juvenile dermatomyositis: adverse reactions are associated with immunoglobulin A content.
Manlhiot C; Tyrrell PN; Liang L; Atkinson AR; Lau W; Feldman BM
Pediatrics; 2008 Mar; 121(3):e626-30. PubMed ID: 18299304
[TBL] [Abstract][Full Text] [Related]
20. [Clinical features of patients with juvenile and adult dermatomyositis].
Szalmás O; Nagy-Vince M; Dankó K; Farkas F
Orv Hetil; 2015 Sep; 156(37):1491-6. PubMed ID: 26552025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
